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at fission yeast centromeres
Michael Thorsen, Heidi Hansen, Michela Venturi, Steen Holmberg* and Genevieve Thon*Abstract
Background: In fission yeast, centromeric heterochromatin is necessary for the fidelity of chromosome segregation.
Propagation of heterochromatin in dividing cells requires RNA interference (RNAi) and transcription of centromeric
repeats by RNA polymerase II during the S phase of the cell cycle.
Results: We found that the Med8-Med18-Med20 submodule of the Mediator complex is required for the
transcriptional regulation of native centromeric dh and dg repeats and for the silencing of reporter genes inserted
in centromeric heterochromatin. Mutations in the Med8-Med18-Med20 submodule did not alter Mediator
occupancy at centromeres; however, they led to an increased recruitment of RNA polymerase II to centromeres and
reduced levels of centromeric H3K9 methylation accounting for the centromeric desilencing. Further, we observed
that Med18 and Med20 were required for efficient processing of dh transcripts into siRNA. Consistent with
defects in centromeric heterochromatin, cells lacking Med18 or Med20 displayed elevated rates of mitotic
chromosome loss.
Conclusions: Our data demonstrate a role for the Med8-Med18-Med20 Mediator submodule in the regulation of
non-coding RNA transcription at Schizosaccharomyces pombe centromeres. In wild-type cells this submodule limits
RNA polymerase II access to the heterochromatic DNA of the centromeres. Additionally, the submodule may act as
an assembly platform for the RNAi machinery or regulate the activity of the RNAi pathway. Consequently,
Med8-Med18-Med20 is required for silencing of centromeres and proper mitotic chromosome segregation.
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Mediator is a large (approximately 1 MDa) protein com-
plex that conveys regulatory signals to RNA polymerase
II (Pol II). The Saccharomyces cerevisiae Mediator was
the first to be characterized but Mediators have since
then been described in many other species. A compara-
tive genomics approach of approximately 70 eukaryotic
genomes shows that although its exact subunit compos-
ition varies, Mediator is conserved across the eukaryotic
kingdom [1]. The Schizosaccharomyces pombe Mediator
consists of at least 20 subunits, all of which appear to
have orthologues in Drosophila melanogaster, Caenor-
habditis elegans and Homo sapiens [2].
Three distinct domains (head, middle and tail) have
been identified by electron microscopy on single Medi-
ator particles from S. cerevisiae [3]. Electron microscopy* Correspondence: gensteen@bio.ku.dk; gen@bio.ku.dk
Department of Biology, University of Copenhagen, BioCenter, Ole Maaløes
vej 5, 2200, Copenhagen, N, Denmark
© 2012 Thorsen et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the oron the S. pombe Mediator also shows a head and a mid-
dle domain, but no tail domain consistent with the lack
of S. pombe orthologues of the S. cerevisiae tail compo-
nents [4]. The head domain can structurally be further
divided (for example, a head domain submodule consist-
ing of Med8-Med18-Med20 is found in both S. pombe
and S. cerevisiae) [5,6]. In S. pombe, Med27 may also be
part of this submodule [7]. A specific role for the Med8-
Med18-Med20 submodule has hitherto not been
described, although it is known from work in S. cerevi-
siae that Med18-Med20 interacts directly with the RNA
Pol II subunits Rpb4 and Rpb7 [8].
Like metazoans, S. pombe has large and complex cen-
tromeres. S. pombe centromeres comprise a central core
surrounded by inner and outer repetitive sequences, imr
and otr respectively. The otr repeats consist of alternating
dh and dg repeats (Figure 1A). Both imr and otr are het-
erochromatic, and reporter genes inserted into the repeats
are silenced [9]. Silencing and heterochromatinization ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Centromeric silencing is alleviated by mutations in the
Med8-Med18-Med20 submodule. (A) Schematic representation of
S. pombe centromere 1. The insertion site of the ura4+ reporter used
below (imr1R(NcoI)::ura4+), the probe for siRNA detection in Figure 3,
and amplicons for the various PCRs performed in this study are
shown. One position of the putative dg promoter (pro) is indicated
relative to the outer repeats (dg and dh) of centromere 1. The
crossed line represents an array of dg and dh repeats next to the
innermost repeats (imr) and the central core (cnt). (B-D) Ten-fold
serial dilutions of cell suspensions were spotted onto the indicated
media. Plates were incubated at 33°C for (B) and (D) and at 37°C for
the med8ts mutant in (C). Expression of ura4+ permits growth in the
absence of uracil and causes sensitivity to 5-FOA. Reduced growth
on 5-FOA for the med18Δ, med20Δ and med8ts mutants indicates
derepression of heterochromatic silencing in these three strains. In
contrast, deletion of other non-essential Mediator subunits in (D)
does not alter growth on 5-FOA. (E) Quantification of ura4+
transcript by RT-qPCR confirms derepression of imr1R(NcoI)::ura4+ in
the med18Δ and med20Δ mutants. The actin transcript (act1+) was
used for normalization. A dcr1Δ strain is shown for comparison. The
strains for this figure were: WT (FY498), med18Δ (MT42), med20Δ
(MT26), med8ts (MT31) med1Δ (MT13), med27Δ (MT11), med31Δ
(MT14), med12Δ (MT6), and dcr1Δ (TP480).
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way [10]. RNAi relies on transcription of the centromeric
repeats by RNA Pol II [11]. Centromeric transcripts are
processed into siRNA by the RNAi machinery, leading to
the recruitment and accumulation at centromeres of sev-
eral interacting protein complexes and histone-modifying
enzymes. These include the Argonaute-containing com-
plex RITS [12], the RNA-dependent RNA polymerase
complex RDRP [13], the Clr4 histone 3-lysine 9 (H3K9)methyltransferase complex CLRC [14-18] and the tri-
methyl H3K4 demethylase Lid2 [19]. These protein com-
plexes are capable of interacting with modified
nucleosomes and, possibly, non-coding centromeric RNAs
and both types of interactions are believed to be required
for proper heterochromatin formation and chromosome
segregation [20,21].
In spite of the central role played by non-coding RNAs
at S. pombe centromeres, little is known regarding the
regulation of transcription in pericentromeric repeats.
Transcription of the dg and dh repeats peaks during the
S-phase of the cell cycle in a window where histone
modifications change as a consequence of other cell-
cycle regulated events [22-24]. Presently, only one pro-
moter controlling transcription of a centromeric repeat
has been described [25]. Consistent with transcription
being performed by RNA Pol II, centromeric transcripts
are poly-adenylated [26] and specific mutations in RNA
Pol II subunits impair heterochromatin formation
[25,27,28]. The involvement of RNA Pol II in hetero-
chromatin assembly indicates that the Mediator complex
may also play a role in heterochromatin biology. Indeed,
deletion of med1+ or med6+ was shown to lead to a
moderate loss of centromeric silencing in a high
throughput study [29]. Further, Med15 was shown to
interact with the chromatin-remodelling factor Hrp1
thus associating chromatin state with the Mediator com-
plex [30]. Mediator has also been associated with regula-
tion of chromatin in HeLa cells as Med12, Med19 and
Med26 interact with the silencing factor REST and the
methyltransferase G9a, which methylates H3K9 at target
genes [31,32]. Here, we present a systematic analysis of
S. pombe Mediator deletion mutants in relation to
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Figure 2 Mutations in the Med8-Med18-Med20 submodule
cause an accumulation of centromeric transcripts. (A) The
steady-state level of centromeric non-coding RNA was estimated by
RT-PCR in the indicated mutants. The actin transcript was used as
reference. (B) RT-qPCR shows that the dh transcript accumulates in
med18Δ and med20Δ strains. (C) Strand specific RT-PCR shows that
med18Δ and med20Δ strains have wild-type ratios of forward to
reverse transcripts. (D) Northern blot analysis shows that the length
of major centromeric transcripts is unchanged in the mutants. The
strains for this figure were: WT (FY498), med18Δ (MT42), med20Δ
(MT26), med8ts (MT31), and dcr1Δ (TP480).
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Med8-Med18-Med20 submodule in the transcriptional
regulation of centromeric repeats and thus in hetero-
chromatin formation, centromere function and chromo-
some segregation.
Results and discussion
A subset of Mediator subunits are required for silencing
of a centromeric ura4+ reporter gene
Genes encoding non-essential subunits of Mediator were
individually deleted in FY498, a strain with the S. pombe
ura4+ gene ectopically inserted in the centromere of
chromosome 1, at imr1R(NcoI) [33]. In addition, a
med8ts allele [34] was crossed into FY498. We found
that silencing of ura4+ at imr1R(NcoI) depends on all
three components of the Med8-Med18-Med20 Mediator
submodule, whereas the other four Mediator subunits
tested (Med1, Med12, Med27, and Med31) were dispens-
able for silencing ura4+ at this location (Figure 1B-D).
A variegated phenotype was observed for both med18Δ
and med20Δ as some clones showed a robust silencing
of ura4+ whereas others showed only weak silencing.
Likewise, deletion of med1+ did occasionally show dere-
pression of centromeric ura4+; however, this was a modest
phenotype compared to the phenotype of med18Δ and
med20Δ. Quantification of ura4+ transcript by RT-qPCR
confirmed derepression of imr1R(NcoI)::ura4+ in strains
with a compromised Med8-Med18-Med20 submodule
(Figure 1E).
dh and dg transcripts accumulate in the absence of
Med18 or Med20
To test whether the derepression observed with the ura4+
reporter extends to the native centromeric repeats, RT-
PCRs and qPCRs were performed to compare the abun-
dance of centromeric transcripts in the wild type and the
med18 and med20 deletion strains. We found that dh and
dg transcripts accumulated following deletion of med20+
or med18+ (Figure 2A, B, and data not shown). The
changes in transcript levels did not appear to be strand
specific (Figure 2C). The size of the transcripts from the
dh and dg repeats estimated by Northern blotting for the
med18Δ and med20Δ mutants were similar to wild type
(Figure 2D). Combined, these data indicate that the
Med8-Med18-Med20 submodule is not involved in choos-
ing promoters or transcription termination sites but that
it more likely influences transcription rate or efficiency of
transcript processing.
The steady-state level of centromeric siRNA depends on
Med18 and Med20
The increased abundance of dh and dg transcripts in
med18Δ and med20Δ mutants could be explained by ei-
ther elevated transcription or reduced processing of the
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processed into siRNA, we performed Northern blot ana-
lyses on total RNA. A random-primed probe was gener-
ated from a PCR fragment corresponding to a region of
the dh repeats known to yield high levels of siRNA [35].
Using this probe clearly showed that the processing of
centromeric transcripts was not abolished when med18+
or med20+ was deleted as siRNA remained easily detect-
able in the mutants. However, the deletion strains con-
tained approximately 20 to 30% less siRNA than the
wild-type control indicative of a partial impairment of
siRNA biogenesis in the two mutants. A strain without
dcr1+ did not show any detectable siRNA in this assay
(Figure 3A, B). Thus, the increase in non-coding RNA
levels did not result in higher, but lower siRNA produc-
tion indicating that wild-type regulation of dh transcrip-
tion is required for effective dh siRNA formation.
Lack of Med18 or Med20 does not influence Mediator
recruitment to centromeres
The modest decrease in siRNA levels observed in the
med18Δ and med20Δ mutants suggested that reducedA
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Figure 3 siRNA levels in med18+ and med20+ deletion strains.
(A) Representative Northern blot of siRNA in wild type and indicated
mutants. Total RNA was run on a 17.5% polyacrylamide/7M urea gel,
blotted and hybridized as described in Materials and Methods.
Ethidium-bromide staining of the same RNA preparations was used
as loading control. (B) Quantification of the blots (n = 4) *P <0.05;
**P =5.2e to −12. The strains for this figure were: WT (FY498),
med18Δ (MT42), med20Δ (MT26), and dcr1Δ (TP480).processing of centromeric transcripts might not on its
own account for the elevated levels of dh and dg tran-
scripts in these mutants. Elevated transcript levels could
also be a consequence of the Med18-Med20-Med8 sub-
module functioning as a negative regulator of transcrip-
tion from the dh and dg repeats in wild-type cells. A
single pericentromeric promoter driving expression of
dg and dh repeats has been described in the literature
[25]. We estimated Mediator occupancy at this promoter
and at the dg repeat regulated by the promoter by chro-
matin immunoprecipitation (ChIP). The Mediator sub-
unit Med7 was pulled down followed by qPCRs for
promoter and dg sequences, respectively. The assay
showed that Mediator is associated with the centromeric
regions tested and that its association is not affected by
deletion of med18+ or med20+ (Figure 4). These observa-
tions are consistent with a direct role of Mediator at
centromeres and suggest that the Med8-Med18-Med20
submodule negatively regulates transcription down-
stream of Mediator association with centromeres.A
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Figure 4 Mediator occupancy (Med7-TAP) at the centromeric
dg promoter and dg repeat in med18+ and med20+ deletion
strains. ChIP analyses show that the relative Mediator occupancy at
(A) the centromeric promoter as well as at (B) the dg repeat is
unchanged in med18Δ and med20Δ mutant strains. The strains for
this figure were: WT (FY498), med18Δ (MT42), and med20Δ (MT26).
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Figure 5 RNA Pol II occupancy at the centromeric promoter
and dg repeat in med18+ and med20+ deletion strains. ChIP
analyses show that compared to wild-type, the RNA Pol II
occupancy at (A) the dg centromeric promoter as well as at (B) the
dg repeat is increased in med18+ and med20+ deletion strains. For
comparison, the RNA Pol II occupancy in a clr4Δ deletion strain is
also shown. *P <0.004; **P <1e to −6. The strains for this figure were:
WT (FY498), med18Δ (MT42), and med20Δ (MT26), and clr4Δ
(PG3423).
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Pol II occupancy on the dg promoter and on the dg
repeat itself
One well-documented function of the Mediator complex
is to regulate RNA Pol II activity [36]. We therefore
assayed RNA Pol II occupancy in pericentromeric
repeats by ChIP in wild-type, med18Δ, med20Δ, and
clr4Δ cells. ChIP-qPCR performed both on the putative
dg promoter and on the dg repeat showed an RNA Pol
II enrichment of two and five fold in med20Δ and
med18Δ, respectively, compared to wild-type. The en-
richment of RNA Pol II in med18Δ is similar to the en-
richment seen in a clr4Δ strain in a parallel experiment
(Figure 5). The fact that Clr4 limits RNA Pol II occu-
pancy at centromeres was previously reported [24] but
the precise mechanism through which exclusion occurs
is unknown. Our results strengthen the view that the
Med8-Med18-Med20 submodule negatively regulates
non-coding RNA transcription at centromeres by redu-
cing the ability of Mediator to recruit RNA Pol II. This
process might be part of the mechanism through which
the Clr4 H3K9 methyltransferase excludes RNA Pol II
from centromeres.
Desilencing of centromeric heterochromatin in med18
and med20 mutants correlates with decreased
H3K9 methylation
The increased abundance of non-coding centromeric
transcripts in strains deleted for med18+ or med20+
prompted us to investigate the methylation levels of his-
tone H3K9. Figure 6 shows that dimethylation of H3K9
was reduced on the putative dg promoter in the med18Δ
and med20Δ mutants. H3K9 methylation at the dg re-
peat next to the promoter was also reduced, but less sig-
nificantly (data not shown). This observation is
consistent with the Med8-Med18-Med20 submodule
acting upstream of Clr4 to facilitate H3K9 methylation.
The Med8-Med18-Med20 submodule might recruit
Clr4, which would in turn inhibit RNA Pol II through
H3K9 methylation. Because RNAi-directed heterochro-
matin formation forms a self-enforcing loop, indirect
effects could also account for reduced H3K9me in Medi-
ator mutants as depicted in the model we present in a
later section.
Mutations in the Med8-Med18-Med20 submodule and
deletion of clr4+ lead to similar changes in transcription
profile
More generally, we noticed that the genome-wide ex-
pression profiles of clr4 and Mediator mutants display
striking similarities indicating the Med8-Med18-Med20
submodule and H3K9me act in concert at many loca-
tions other than centromeres. A total of 42/110 genes
upregulated more than 1.5x in clr4-481 [26] areupregulated more than 2x in the med8ts mutant ([37];
164 genes are upregulated more than 2x in the
med8ts mutant). A total of 24/58 genes upregulated
more than 1.5x in clr4Δ are upregulated more than
2x in the med8ts mutant. These genes are enriched in
large subtelomeric regions extending approximately
100 kb into chromosomes 1 and 2; 39/164 genes
upregulated more than 2x in the med8ts mutant are
subtelomeric. These regions share properties with
centromeric heterochromatin [26,38,39] The same sub-
telomeric gene clusters are controlled by Spt6 [40]
suggesting Spt6, Clr4, and the Med8-Med18-Med20
Mediator submodule cooperate in heterochromatic
gene silencing both at centromeres and at other
chromosomal locations.
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Figure 6 Mutations in the Med8-Med18-Med20 submodule
compromise H3K9 methylation at the centromeric dg
promoter. ChIP analyses show that the level of H3K9 dimethylation
at the centromeric dg promoter is reduced in med18Δ and med20Δ
mutants relative to wild-type. A clr4Δ strain was processed in parallel
for comparison. *P <0.003. The strains for this figure were: WT
(FY498), med18Δ (MT42), med20Δ (MT26), and clr4Δ (PG3423).
Table 1 Mini-chromosome loss rate is higher in strains
deleted for med18+ or med20+
Strain Half sectored White Loss Rate
WT 1 4012 0,025%
clr4Δ 85 2181 3,9%
med18Δ 26 3195 0,8%
med20Δ 7 2339 0,3%
A
WT med18Δ
med20Δ clr4Δ
YES YES+TBZB
WT
med18Δ
med20Δ
Figure 7 Deletion of med18+ or med20+ impairs centromere
function. (A) A non-essential mini-chromosome, Ch16m23::ura4+-
Tel[72], is frequently lost in strains deleted for med18+, med20+ or
clr4+. Cells containing the mini-chromosome form white colonies on
medium with low concentration of adenine while cells lacking the
mini-chromosome form red colonies. Loss of the mini-chromosome
in the first cell division after plating results in a half-sectored colony.
(B) Deletion of med18+ or med20+ renders the cells sensitive to the
microtubule destabilizing agent thiobendazole (12 μg/ml). The
strains for this figure were: WT (FY520), med18Δ (TP527), med20Δ
(TP527), and clr4Δ (PG3420).
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med20Δ strains
Defects in heterochromatin impair the association of
cohesins with centromeric regions and increase mitotic
and meiotic chromosome loss [33,41,42]. To further in-
vestigate whether mutations in the Mediator complex
affect the functionality of centromeres, we measured the
rate of mitotic loss of a non-essential mini-chromosome,
Ch16m23::ura4+-Tel[72] [43], in med18Δ, med20Δ and
wild-type strains. For comparison we included a clr4Δ
strain in the analysis. Chromosome segregation was
affected in med18Δ and med20Δ mutants corroborating
the alleviated-silencing phenotype of these mutants.
These strains lost their mini-chromosome in approxi-
mately 0.3 to 0.8% of cell divisions compared to approxi-
mately 4% in a clr4Δ background and more than 0.025%
in wild-type cells (Figure 6A and Table 1). These
changes correspond to a 32- and 12-fold increase in
mini-chromosome loss rates in med18Δ and med20Δ, re-
spectively, compared to wild-type. In addition, strains
without Med18 or Med20 were sensitive to the micro-
tubule destabilizing agent thiobendazole (Figure 7B), fur-
ther implicating Med18 and Med20 as crucial factors for
maintaining centromere function.
Conclusions
The central observations presented here, that long
centromeric non-coding RNAs accumulate in mutants
compromised in the Med8-Med18-Med20 submodule of
Mediator, that centromeric H3K9me is reduced in these
mutants, and that the levels of siRNAs are not dramatic-
ally altered but, if anything, slightly reduced in themutants can be understood as depicted in Figure 8.
The model in Figure 8 proposes that one role of the
Med8-Med18-Med20 Mediator submodule is to prevent
the recruitment of RNA Pol II to centromeric hetero-
chromatin. By analogy with S. cerevisiae where the
Med8-Med18-Med20 submodule was reported to inter-
act with the Rpb4/Rpb7 RNA polymerase II subunit
complex [8], we propose that S. pombe Med8-Med18-
Med20 also interacts with Rpb4/Rbp7. The structural
studies monitoring Med18-Med20 interaction with
Rpb4/Rpb7 in S. cerevisiae reveal that Med18-Med20
modulates the conformation of RNA Pol II, regulating its
M di te a or
Med8Med20
M d18e
Centromeric chromatinRpb4Rpb7
Non-coding RNA H3K9me
RNA Pol II
Clr4
Rpb1
RNAi
Rpb2
siRNA
Non-RNAi
targeted
RNA
Figure 8 Model illustrating the effect of the Med8-Med18-Med20 submodule on heterochromatin. Med8-Med18-Med20 may block
recruitment of RNA Pol II to the centromeric chromatin by interacting with Rpb4/Rpb7. Additionally, the submodule may stimulate the activity of
RNAi and thus influence the methylation level of H3K9 in centromeric chromatin. Further, Med8-Med18-Med20 in concert with Rpb1/Rpb2 may
decide the fate of non-coding transcripts by directing them towards the RNAi machinery or to other downstream processes. See text for details.
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Med18-Med20 submodule is likely to affect RNA Pol II
function. In S. pombe, the Rpb7 subunit of RNA Pol II is
required for initiation of transcription of centromeric
non-coding RNAs. In the rpb7-G150D mutant reduced
transcription initiation at centromeres leads to compro-
mised heterochromatin which allows for more spurious
transcription and accumulation of non-coding transcripts
[25]. We propose that the Med8-Med18-Med20 submo-
dule limits centromeric transcription in wild-type cells
by inhibiting transcription initiation through Rbp4/Rpb7.
Mechanistically, the interaction between the Med18-
Med20 sub-complex and the Rpb4/Rpb7 sub-complex of
Pol II has been proposed to alter the conformation of
the Pol II clamp domain to facilitate opening of its
active-site cleft and thereby the access of promoter DNA
to the Pol II cleft [44]. This interaction would facilitate
pre-initiation-complex (PIC) formation. We suggest that
in heterochromatin specific interactions of other compo-
nents with Mediator and/or Pol II might prevent clamp
movement and thereby the productive interaction of Pol
II with DNA.
Since the above proposed function of Med8-Med18-
Med20 might not account for the decrease in siRNA or
H3K9me in the mutants, we suggest that the Med8-
Med18-Med20 submodule also facilitates the processing
of long non-coding RNAs into siRNA. This second
function might be carried out together with the two lar-
gest S. pombe RNA Pol II subunits, Rpb1 [28] andRpb2 [27]. A mutation in Rbp2, rpb2-m203, increases
the steady-state levels of centromeric transcripts and
reduces siRNA to undetectable levels [27]. The rpb2-
m203 phenotype has been taken to suggest that Rpb2
provides an interaction interface with RNAi complexes
and/or a means of distinguishing non-coding centro-
meric transcripts from mRNA, triggering processing of
the former into siRNA [27]. This presumed function
of RNA Pol II, which would be compromised by the
rpb2-m203 mutation, may also be affected by mutation
in the Med8-Med18-Med20 submodule. A non-
mutually exclusive possibility is that Med8-Med18-
Med20 facilitates processing of centromeric non-coding
RNA into siRNA together with Rpb1 [28]. The S.
pombe C-terminal domain of Rpb1 contains 28 con-
served YSPTSPS repeats acting as an assembly platform
for various mRNA processing factors, thus coupling
transcription to pre-mRNA processing and export. A
mutant form of Rpb1 (rpb1-11) retaining 16 of the 28
hepta-repeats apparently does not affect transcription of
the pericentromeric repeats, but nevertheless compro-
mises downstream RNAi function [28]. As for Rpb2,
given the ubiquitous interactions between the Mediator
complex and active RNA Pol II, it seems plausible that
a mutation in Med8-Med18-Med20 might disturb the
Rpb1-dependent RNAi machinery assembly function.
Alternatively, the Med8-Med18-Med20 submodule
might itself be a site where pre-siRNA processing is
regulated.
Table 3 Oligonucleotides used in the study
Name Sequence
dhH-siRNA TACTGTCATTAGGATTAGCACA
Cen-dh-FOR2 CGACAAACTTCATGTTACAAGTC
GTO265 GCTATTCAGCTAGAGCTGAGGG
GTO266 CTTCGACAACAGGATTACGACC
GTO223 GAAAACACATCGTTGTCTTCAGAG
GTO226 TCGTCTTGTAGCTGCATGTGA
OKR70 GGCATCACACTTTCTACAACG
OKR71 GAGTCCAAGACGATACCAGTG
Act1 q-PCR FW CTGTTTTGTCTTTGTATGCC
Act1 q-PCR RV TAAGGTAGTCAGTCAAGTCA
dhA q-PCR FW GCAAACAGACCCTCATACAG
dhA q-PCR RV CAAGGACTAAGCCCAAGCAC
ura4 q-PCR FW CGTGGTCTCTTGCT TTGG
ura4 q-PCR RV GTAGTCGCTTTGAAGGTTAGG
p33F TGCAAGTGGAAAGTGGCTTCA
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Zhu and colleagues [45], published during the writing of
this article, reports an accumulation of centromeric non-
coding RNA and reduced processing of the dh repeat
transcript into siRNA in a med20Δ strain. In addition, an
independent large-scale epistasis map revealed genetic
interactions between subunits of the Mediator and RNAi
and heterochromatin components [29]. Neither med8
nor med18 mutants were included in this screen but
probing the bioGRID [46] with Osprey [47] lists 101 gen-
etic interactions for med20 including interactions with
dcr1+, ago1+, hrr1+, swi6+, cid12+, clr3+, hda1+, hst2+,
pob3+, set3+, swc2+ and epe1+. These interactions with
heterochromatin-associated factors are fully consistent
with the notion that the Med8-Med18-Med20 submo-
dule participates in S. pombe heterochromatin formation.
The data presented here, which are corroborated by
Carlsten et al. [45], clearly demonstrate a role for Medi-
ator in regulating centromeric chromatin.p33R TCGACCACCCTGACTTGTTCTC
p30F CCTGTTGATTCGGCACCTTTG
p30R TGGAGAACGACTGTGAAGAGA
oMiT127 CCGAAAGCCTCGATATCATC
oMiT128 GAGCATGGTGGTGGTTATGG
oMiT142 ACCGTAGTACGACGATGATGTGTTTMethods
Strains and primers
The S. pombe strains used in this study are listed in
Table 2 and the primers are listed in Table 3.oMiT143 ACATTCCGCACAAGGTCTAGTACA
Table 2 Schizosaccharomyces pombe strains used in the
study
Name Genotype Source
FY498 h+ ura4-DS/E ade6-210 imr1R(NcoI)::ura4+ori1 [9]
MT6 h+ ura4-DS/E ade6-210 imr1R(NcoI)::ura4+ori1
med12Δ::KanMX
This study
MT11 h+ ura4-DS/E ade6-210 imr1R(NcoI)::ura4+ori1
med27Δ::KanMX
This study
MT13 h+ ura4-DS/E ade6-210 imr1R(NcoI)::ura4+ori1
med1Δ::KanMX
This study
MT14 h+ ura4-DS/E ade6-210 imr1R(NcoI)::ura4+ori1
med31Δ::KanMX
This study
MT26 h+ ura4-DS/E ade6-210 imr1R(NcoI)::ura4+ori1
med20Δ::KanMX
This study
MT42 h+ ura4-DS/E ade6-210 imr1R(NcoI)::ura4+ori1
med18Δ::KanMX
This study
TP480 h+ ura4-DS/E ade6-210 imr1R(NcoI)::ura4+ori1
dcr1Δ::KanMX
This study
FY520, h+ ura4-DS/E ade6-210/216 Ch16m23::ura4+-
Tel[72]
[43]
TP528 h+ ura4-DS/E ade6-210/216 Ch16m23::ura4+-
Tel[72] med20Δ::KanMX
This study
TP527 h+ ura4-DS/E ade6-210/216 Ch16m23::ura4+-
Tel[72] med18Δ::KanMX
This study
PG3420 hA Ch16m23::ura4+-Tel[72] leu1-32 ura4-DS/E
ade6-210/216 clr4Δ::LEU2
[17]
PG3423 mat1-Msmt-0 mat2-P(XbaI)::ura4+ leu1-32 ura4-
DS/E ade6-210 clr4Δ::LEU2
[17]RT-PCR/qPCR
RNA extraction and RT-PCR were as in [48] except for
the final step where quantification was performed by
ethidium-bromide staining using a Bio-Rad Laboratories
imaging station and the Quantity One image analysis
software (Bio-Rad Laboratories, Hercules, CA, USA).
Primer sequences are listed in Table 3. For RT-PCR, the
oligonucleotides GTO-265 and GTO-266 were used
to amplify ura4+ and ura4-DS/E; GTO-223 and GTO-
226 were used to amplify RNA originating from centro-
meric repeats or mating-type region; OKR70 and
OKR71 were used to amplify actin mRNA. Strand-
specific RT-PCR was achieved by using GTO-226 to
prime reverse transcription on centromeric forward
transcripts or GTO-223 on centromeric reverse tran-
scripts prior PCR amplification.
RNA used in RT-qPCR was isolated using an RNeasy™
mini kit (Qiagen, Hilden, Germany) and an RNase-Free
DNase set (Qiagen, Hilden, Germany). Reverse tran-
scription of the purified RNA was performed using the
RevertAidTM First Strand cDNA Synthesis Kit (Thermo
Fisher Scientific, Waltham, MA, USA) and random hex-
amer primers. qPCR was performed on a CFX96 real
time PCR system (Bio-Rad Laboratories, Hercules, CA,
USA) using the QuantiTect SYBR Green PCR kit
(Qiagen, Hilden, Germany) supplied with SYBR Green
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formed for each of the biological triplicates. Technical
replicates with standard deviations above 10% were
repeated or excluded from the experiment. Primers used
to amplify act1+ and the dh repeat are shown in Table 3.
Chromosome-loss assay
Mitotic chromosome loss was assayed as previously
described [9] using cells containing the ade6-M210 allele
on chromosome 3 and the ade6-M216 allele on the non-
essential minichromosome Ch16m23::ura4+-Tel[72] [43].
Cells with this genotype are phenotypically Ade+ due to
the interallelic complementation between ade6-M210 and
ade6-M216. They form white colonies on media contain-
ing low concentrations of adenine. Loss of Ch16m23::
ura4+-Tel[72] results in red colonies or sectors. White
and sectored colonies were counted following plating of
the strains of interest on yeast extract plates to which no
adenine had been added. The rate of minichromosome
loss was determined as the number of colonies with a red
sector equal to or greater than half the colony size (that
is, the number of cells having lost their minichromosome
at the first division after plating) divided by the number
of white or sectored colonies.
Northern blot
For siRNA Northern blots, total RNA was isolated with
Tri Reagent (Sigma Chemical Co., St. Louis, MO, USA)
and 20 μg RNA was run on a 17.5% polyacrylamide/7 M
urea gel and blotted onto a positive nylon membrane
(Roche Diagnostics, Mannheim, Germany). siRNA were
detected using a random-primed probe radioactively la-
beled with [α-32P]-dCTP (3000 Ci/mmol, PerkinElmer,
Waltham, MA, USA). The template for random priming
was a dh repeat PCR product amplified from genomic
DNA with the dhH-siRNA and Cen-dh-FOR2 primers.
Northern blots detecting the dg and dh repeats were
obtained following electrophoresis of 10 μg total RNA
prepared by a hot phenol protocol from the strains of
interest. The gels used were 1% agarose in MOPS buffer
with 6.7% formaldehyde. RNA was blotted onto a
Hybond-XL membrane (GE Healthcare, Little Chalfont,
United Kingdom). The dg and dh repeats were detected
by a random-primed [α-32P]-dCTP radioactively labeled
probe made on PCR products amplified from genomic
DNA using p30F and p30R (dh repeat) or p33F+p33R
(dg repeat). Hybridizations were performed overnight at
42°C in PerfectHyb PLUS hybridization buffer (Sigma
Chemical Co., St. Louis, MO, USA).
Chromatin immunoprecipitations
ChIP was performed according to standard procedures.
Antibodies used to immunoprecipitate RNA Pol II and
H3K9me2 were ChIPAb RNA Pol II (Merck Millipore,Billerica, MA, USA) and histone H3 (dimethyl K9) anti-
body ChIP Grade ab1220 (Abcam, Cambridge, MA,
USA), respectively. Protein G Dynabeads were used to
pull down the antibody captured proteins. Rabbit Anti-
Mouse Immunoglobulins (Dako, Glostrup, Denmark)
were covalently coupled to the surface of Dynabeads
with the Dynabeads Antibody Coupling Kit (Invitrogen,
Life Technologies, Carlsbad, CA, USA) and these beads
were used to pull down the Mediator complex through a
TAP-tagged Med7. Presence of RNA Pol II, Mediator or
dimethyl H3K9 was detected by qPCR using the primers
dhA q-PCR FW and dhA q-PCR RV for the dh repeat,
oMiT142 and oMiT143 for the dg repeat, or oMiT127
and oMiT128 for the putative promoter.
Abbreviations
ChIP: Chromatin immunoprecipitation; RNA Pol II: RNA polymerase II;
RT-PCR: Reverse transcription PCR; RT-qPCR: Quantitative reverse
transcription PCR.
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